Physiological, Behavioural and Subjective Measures of Listening Effort

Sponsor
Sonova AG (Industry)
Overall Status
Completed
CT.gov ID
NCT03761927
Collaborator
(none)
17
1
3
6.7
2.5

Study Details

Study Description

Brief Summary

Participants will perform two different listening tasks: (1) listening to, and repeating back, sentence lists presented in noise, and (2) listening to short radio excerpts and answering subsequent comprehension questions. At the same time participants are required to perform a manual target-tracking task on a touch screen. During this study, continuous, non-invasive physiological measurements (heart rate, skin conductance and hemoencephalography) will be made from participants. Using this paradigm we will be assessing the effect of different hearing aid processing algorithms on listening effort. The study takes the form of a three factor (listening task x algorithm x signal-to-noise ratio), within-subjects design. Each participant performs each listening task (about 4min long each) with each algorithm (reference, noise reduction I, noise reduction II), at two signal-to-noise ratios (+4 decibel and 0 decibel) twice (test-retest).

Condition or Disease Intervention/Treatment Phase
  • Device: Hearing Aid without NR enabled
  • Device: Hearing Aid with NR(1)
  • Device: Hearing Aid with NR(2)
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
17 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Effect of Noise Reduction Algorithms on Physiological, Behavioural and Subjective Measures of Listening Effort
Actual Study Start Date :
Oct 8, 2018
Actual Primary Completion Date :
Mar 29, 2019
Actual Study Completion Date :
Apr 30, 2019

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Hearing Aid without NR enabled.

Hearing Aid without Noise Reduction (NR) enabled serves as reference condition.

Device: Hearing Aid without NR enabled
Each participant will be fitted with noise reduction disabled. Disabled means that no sound processing algorithm that removes noise from the speech signal is active.

Experimental: Hearing Aid with NR(1)

Hearing Aid with Noise Reduction I (NR) enabled.

Device: Hearing Aid with NR(1)
Each participant will be fitted with the noise reduction program on the same hearing aid. The principle of the noise reduction algorithm is to remove noise from a speech signal with the aim of improving the speech intelligibility and comfort.

Experimental: Hearing Aid with NR(2)

Hearing Aid with Noise Reduction II (NR) enabled.

Device: Hearing Aid with NR(2)
Each participant will be fitted with a second noise reduction program on the same hearing aid. The parameterization of this NR algorithm differs from that in NR(1).

Outcome Measures

Primary Outcome Measures

  1. Heart rate variability data [6 weeks]

    Heart rate variability will be recorded from the participant both before and during the performance of the auditory tasks. Analyses will be carried out relative to the baseline recording (made before the auditory tasks), in order to account for differences in baseline physiological activity. Heart rate variability will be analysed in both the time [ms] and frequency [ms squared] domains.

  2. Skin conductance data [6 weeks]

    Skin conductance will be recorded from the participant both before and during the performance of the auditory tasks. Analyses will be carried out relative to the baseline recording (made before the auditory tasks), in order to account for differences in baseline physiological activity. It is planned to analyse mean levels of skin conductance [micro-Siemens].

Secondary Outcome Measures

  1. Hemoencephalography data [6 weeks]

    Hemoencephalography will be recorded from the participant both before and during the performance of the auditory tasks. Analyses will be carried out relative to the baseline recording (made before the auditory tasks), in order to account for differences in baseline physiological activity. Hemoencephalography will be analysed simply as the ratio of the blue and red light [%] during auditory task performance.

  2. Dual-task performance test 1 [6 weeks]

    Performance on the secondary tracking task will be analysed in order to observe whether there is a dual-task cost associated with performing both tasks simultaneously. Typically the level of degradation on the secondary task is thought to reflect an increased listening effort (provided that the primary task performance remains stable). Accordingly, success on the primary task will also be monitored and used in analyses (speech intelligibility in [%] correct). For the Secondary task performance the reaction time [ms] will be analysed.

  3. Dual-task performance test 2 [6 weeks]

    Performance on the secondary tracking task will be analysed in order to observe whether there is a dual-task cost associated with performing both tasks simultaneously. Typically the level of degradation on the secondary task is thought to reflect an increased listening effort (provided that the primary task performance remains stable). Accordingly, success on the primary task will also be monitored and used in analyses (comprehension questions [numbers] correct after listening to radio excerpts). For the Secondary task performance the reaction time [ms] will be analysed.

  4. Subjective Listening Effort rating [6 weeks]

    Subjective Listening Effort will also be assessed through self-reported individual listening effort on a 14 point scale from "only noise" to "no effort" after each auditory task.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 99 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Healthy outer ear (without previous surgical procedures)

  • Ability to fill in a questionnaire conscientiously

  • Informed Consent as documented by signature

  • Minimum 1 year hearing aid experience

  • Moderate-Severe (N3-N5) hearing loss or Normal Hearing

Exclusion Criteria:
  • Contraindications to the MD in this study, e.g. known hypersensitivity or allergy to the investigational product

  • Limited mobility and not in the position to attend weekly appointments

  • Inability to produce a reliable hearing test result

  • Massively limited dexterity

  • Known psychological problems

  • Known central hearing disorders

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sonova AG Stäfa Switzerland 8712

Sponsors and Collaborators

  • Sonova AG

Investigators

  • Principal Investigator: Juliane Raether, Sonova AG

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Sonova AG
ClinicalTrials.gov Identifier:
NCT03761927
Other Study ID Numbers:
  • Sonova2018_36
First Posted:
Dec 3, 2018
Last Update Posted:
Jul 12, 2019
Last Verified:
Jul 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 12, 2019